1. Serial measurements of total body calcium have been made by prompt y-neutron activation analysis in 13 patients with inflammatory bowel disease over a mean period of 23 months. Changes in spinal trabecular bone mineral density and radial shaft bone mineral content were also assessed by using quantitative computed tomography and single photon absorptiometry, respectively.
INTRODUCTION
Several groups have reported an increased prevalence of osteoporosis in patients with inflammatory bowel disease [l-31. Both cortical and trabecular bone loss may occur and some patients develop severe osteoporosis with fractures, loss of height and disability. Rapid decreases in spinal trabecular bone mineral density (BMD) have also been demonstrated in one study of 54 patients in whom the mean annual rate of bone loss was 3% [4] .
Total or partial body calcium can be measured by in vivo neutron activation analysis [5] and predominantly reflects peripheral cortical bone mass. Traditionally, a delayed y-counting technique has been used in which the activation of 48Ca by neutron irradiation is followed by a counting period in a low background whole body monitor. More recently, the technique of prompt y-neutron activation analysis has been described in which y-radiation emitted from the activation product of 40Ca is counted during the irradiation period [6, 71. This technique has been used in the present study to investigate serial changes in total body calcium (TB,,) in a group of patients with inflammatory bowel disease over 9 mean period of 2 years; changes in bone mass in the spine and radial shaft have also been assessed over the same time period. participate in the study, which involved travelling to Swansea for TB,, measurements (Table 1) . Four patients (nos. 3, 5, 6 and 11) had initial spinal trabecular BMD values > 2 SD below the normal age-and sex-matched values: patient no. 3 also had multiple vertebral crush fractures. One male had ulcerative colitis (patient no. 8) and the remainder had Crohn's disease. Patient nos. 1-5, 7 and 9-13 with small-bowel Crohn's disease had undergone at least one intestinal resection. Patient no. 13 had both colonic and small-bowel Crohn's disease, whilst patient no. 6 had disease limited to the sigmoid colon. During the study one patient (no. 10) received sodium fluoride (20 mg, three times daily) and calcium supplements, and one patient (no. 3) was given an oestradiol implant (50 mg) 4 months before her last measurement. All patients except two (nos. 4 and 11) received corticosteroids during the course of the study.
Measurements were performed over a mean period of 23 months (range 20-26 months). Three serial measurements of TB,,, spinal BMD and radial bone content (BMC) were made in seven patients, and two in the remaining six patients; however, one patient (no. 5) had only a single measurement of radial BMC. The study was approved by the local ethical committee.
Measurement of TB,,
TB,, was measured by detecting the prompt y-radiation emitted after neutron capture in 40Ca during irradiation. The neutron activation instrument contained a 4-5 GBq californium neutron source (252Cf). The subject was scanned on a motorized couch between the neutron source and two n-type hyperpure germanium yray detectors of 20% relative efficiency and high energy resolution (1.9 keV at 1.33 MeV). A full description of the instrument has been given previously [6] . Activation parameters for the prompt technique are compared with those of the delayed method in Table 2 .
The suitability of the instrument for the measurement of calcium was assessed by investigating: (i) the measurement uniformity with width and depth of subject, and (ii) the precision of repeated measurements [7] .
Using a ten-piece anthropomorphic phantom (height 1700 mm, water-filled weight 70 kg) the anterior-posterior measurement uniformity from a bilateral irradiation was determined by irradiating a small titanium plate at different positions within the phantom. Titanium has an intense prompt capture y-ray at 6417 keV, only 3 keV below that of calcium. The uniformity (defined as the root mean square deviation about the mean) varied from k 17.1% to k6.7% for phantom sections of anterior-posterior thickness 120 mm and 200 mm, respectively. Measurements were made to within 10 mm of the anterior and posterior surfaces. The uniformity in the lateral direction was * 23.7% measured to within 20 mm of the surface of a 300 mm wide section of the tenpiece phantom.
The combined uniformity and linearity of response was assessed by measurement of a spine and rib phantom in which the mass and position of calcium could be varied. The phantom was immersed in a tank filled with water to a depth of 200 mm. Linear regression analysis of calcium content against calcium y-ray counts gave a high correlation coefficient ( r = 0.986, P < O.OOl), indicating good agreement with a coefficient of variation about the regression line of 7.8%.
The measurement precision was determined from eight scans (over a 2 week period) of a Bush-type body phantom filled with a homogeneous tissue equivalent solution containing 1000 g of calcium. The precision (expressed as the coefficient of variation) for a skin dose equivalent of 6.4 mSv (neutron quality factor= 10) was 2.6%. Because of the radiation dose involved, measurement of precision in vivo could not be undertaken and an estimated precision of about 5% was derived from spectra in vivo. This value mainly reflects the uncertainty associated with calculation of the net counts in the calcium y-ray peaks; for example, for the spectrum shown in Fig. 1 y-Ray energy (keV) Figure 1 . A portion of the prompt y-ray spectrum recorded by one detector from patient 4. The calcium yray peaks used in the analysis are labelled (Ca). Other prominent peaks arise from chlorine (C1).
habitus and subject repositioning. However, the former was not significant as tested by estimating the body mass index [BMI, ~eight/(height)~].
Patients were scanned from shoulder-to-knee in the prone and supine positions; the neutron beam extended about 100 mm beyond these limits as determined from the 50% thermal neutron fluence point. A scan speed of 0.5 mm/s was used so that the total measurement time for most patients was about 1 h. The scan length was divided into four equal segments and the data acquired from each segment were automatically stored so that a longitudinal profile of calcium content could be obtained. The segment spectra (eight per detector) were then added to give two bilateral spectra, one from each detector. A portion of a representative spectrum from patient no. 4 is shown in Fig. 1 . Counts within the principal calcium yradiation peaks at 6420, 5909 and 5398 keV were summed and corrected for background. The 1943 keV y-ray was not included in the analysis.
Quantitative computed tomography
Spinal trabecular BMD was measured in the first three lumbar vertebrae on a Philips 350 X-ray CT scanner using a modification of the method of Cann & Genant [8] . Subjects were positioned with the lumbar spine over a phantom made of a water equivalent plastic, which contained solutions of dipotassium hydrogen phosphate and water. Scans were made through the middle of each vertebra at right angles to the long axis using a slice thickness of 6 mm and a field of view of 400 mm. A special low-dose parameter set (tube voltage 120 kVp, tube current 100 mA) was used and this gave weighted whole-body dose equivalents of 0.10 and 0.17 mSv for men and women, respectively.
An irregular region of interest was drawn in the anterior part of each lumbar body avoiding obvious areas of heterogeneity, and the mean computed tomography number was corrected for deviation of the water value from zero [9]. The results were corrected for the contribution of non-mineral components to the attenuation coefficient, using published tissue composition data [lo] . Over 2 years precision in vitro was 1.1% (coefficient of variation, n = 12) whilst the short-term precision in vivo, cdculated from duplicate measurements in six patients over a time period of 6 h or less, was 2.6%, giving a combined precision of 2.8% [ l 11.
Single photon absorptiometry
BMC was measured at the junction of the distal onethird and proximal two-thirds of the left radius by using an in-house single photon absorptiometer. This instrument was based on the original design of Sorensen & Cameron [12] ; it incorporated an 12JI radiation source and was calibrated against a commercial instrument (Novo Densitometer GT35). BMC was expressed in units of g/cm, and the ratio of BMC to bone width (BW) in g/cm2. Over a period of 14 months, precision in vitro for BMC/ BW in an aluminium/Perspex phantom was 2.4% ( n = 128) and precision in vivo in a normal male subject was also 2.4% ( n = 43).
Statistical analysis
A separate linear regression of each measured variable against time was performed on each patient. For each variable the mean annual rate of change was obtained from pooled estimates of the slopes by analysis of covariance. An F test was used to determine whether the slope obtained differed simcantly from zero.
Correlations between the slopes and baseline values of all three measured variables were examined by linear regression analysis. The confounding effects of sex and age were eliminated, in the case of sex by expressing values as differences from sex-specific means, and for age by using partial correlation.
RESULTS
Individual changes in TB,,, radial BMC/BW and spinal trabecular BMD are shown in Table 1 , expressed as the percentage change per year. The mean annual rate of change for each variable is shown in Table 3 . TB,, showed a mean annual decrease of 7.8% (-12.0 to -3.7%); the corresponding changes in radial BMC/BW and spinal trabecular BMD were -2.1% (-3.4 to 0.05 < P<O.l), respectively. Of the three patients with an increase in spinal BMD, one (patient no. 3) had received an oestrogen implant 4 months before the final measurement and one (patient no. 10) had been given sodium fluoride, 20 mg three times daily, throughout the course of the study. Patient no. 3 also showed an increase in radial BMC/BW.
No significant correlations were found between the rate of change in any of the three variables measured (Table 4) 
DISCUSSION
Our results demonstrate rapid decreases in TB,, in some patients with inflammatory bowel disease and are consistent with the increased risk of osteoporosis reported in this group of patients [l-31. There are no published data on changes in TB,, in such patients, although we have recently shown rapid rates of spinal trabecular bone loss in a larger group of patients with inflammatory bowel disease. Because of the relatively large radiation dose involved in TB,, measurements we were unable to include a control group in this study; however, Aloia er al. [13] reported annual loss rates of only 0.45% in a group of normal postmenopausal women. The 95% confidence limits for TB,, in the present study were wide and probably reflect both the imprecision of the measurement technique and the clinical heterogeneity of the patients studied. Nevertheless, the decrease observed in TB,, in the group as a whole was highly s i m c a n t , the mean value of 7.8% suggesting that considerable bone loss occurred from sites other than those assessed in this study. Biochemical indices of calcium balance, such as urinary calcium excretion, were not assessed in these patients, but it is unlikely that there was any systematic error in the TB,, measurement from one set of measurements to the next, since no sigruficant changes in body habitus occurred during the course of the study, and in the absence of such changes variation in 4LCa production by neutrons should not occur. The correlations between bone mass at different skeletal sites within individuals are in agreement with other published data [14] , whilst the lack of relationship between rates of bone loss at different sites is consistent with a number of studies demonstrating differential rates of bone loss both between cortical and trabecular bone and between different skeletal sites [15-171. The mean annual decrease of 2.1% in radial BMC/BW was also statistically significant and higher than the reported normal age-related rate of bone loss at this site of < 1% [18] . This increased loss at a site predominantly composed of cortical bone is in keeping with the decrease observed in TBc,, of which peripheral cortical bone is the largest component. In the present study, changes in spinal trabecular BMD did not achieve statistical significance, although losses occurred in 10 of the 13 patients, and two of those in whom spinal BMD increased were receiving treatment for osteoporosis; moveover, the mean annual loss of 2.5% was greater than would be expected in healthy subjects of a similar sex and age distribution.
The pathogenesis of osteoporosis associated with intestinal disease is multifactorial; corticosteroid therapy is likely to play an important role in some patients [19, 201, [26] . In our small group of patients it was not possible to assess the relative contributions of these risk factors; many of those studied had relatively severe inflammatory bowel disease and all but two were receiving corticosteroids. However, patients with severe disease, intestinal resection and high dose corticosteroid therapy are most likely to be at risk, especially in the presence of secondary amenorrhoea or premature menopause.
The recent development of safe, precise techniques which measure BMD at potential fracture sites enables identification of those individuals who are most likely to be at risk from fracture. Fracture risk is closely related to bone mass [27] and some prospective studies indicate that future fracture risk can be predicted from a single measurement of BMD [28, 29] . The increased prevalence of osteoporosis associated with inflammatory bowel disease together with the rapid rates of bone loss in some patients indicate that, where resources are available, BMD should be routinely monitored, particularly where known major risk factors exist. Measurement of TB,, is impracticable in large numbers of patients because of its lack of availability and the relatively high radiation dose associated with its measurement; dual energy X-ray absorptiometry, which enables BMD measurements in the spine, femur and whole body, is the most appropriate technique presently available [30] . In patients with a low BMD or rapid rates of bone loss, prophylactic or therapeutic measures should be considered. Long-term oestrogen replacement during and after the menopause prevents bone loss and reduces fracture rate in normal women [31, 321; more information is required about the effectiveness of such therapy in women with malabsorption, particularly those receiving corticosteroid therapy. The long-term effects on bone mass and fracture rate of other therapeutic regimens, such as sodium fluoride, calcitonin and bisphosphonates, also require further study, both in primary osteoporosis and in bone loss associated with intestinal disease. Finally, known risk factors such as cigarette smoking and excessive alcohol consumption should be avoided, whilst physical activity and adequate dietary calcium intake should be encouraged; corticosteroid therapy should be kept to a minimum with regular revision of the dose required.
